Parolari Alessandro, Mussoni Luciana, Frigerio Marta, Naliato Moreno, Alamanni Francesco, Galanti Andrea, Fiore Giuseppe, Veglia Fabrizio, Tremoli Elena, Biglioli Paolo, Camera Marina
Department of Cardiac Surgery, University of Milan, Italy.
J Thorac Cardiovasc Surg. 2005 Aug;130(2):303-8. doi: 10.1016/j.jtcvs.2004.11.002.
This study investigated whether the activation of coagulation, fibrinolysis, and endothelium occurring during the first postoperative month after on-pump coronary artery bypass surgery differs from that after off-pump coronary artery bypass grafting.
Thirty-five patients candidates to coronary surgery were randomized to undergo on-pump (n = 18) or off-pump (n = 17) coronary artery bypass grafting. Blood samples were collected before the intervention and to 1 month after surgery.
Prothrombin fragment F1.2, thrombin-antithrombin complex, and D-dimer increased after surgery and were persistently higher than preoperative values as late as 30 postoperative days in both on- and off-pump groups; higher levels of these variables were detected after on-pump surgery relative to off-pump surgery only at the time point after termination of cardiopulmonary bypass (fragment F1.2 and thrombin-antithrombin complex) or from bypass end to 8 postoperative days (D-dimer). Fibrinogen levels decreased after surgery and then increased in parallel in both groups to 8 days after surgery. The von Willebrand factor level increased postoperatively in both groups and returned to baseline 30 days after surgery; it was higher after on-pump surgery from bypass end to 8 postoperative days. Soluble vascular cell adhesion molecule 1 was increased significantly from baseline in both groups 30 days after surgery, with no difference between groups.
Patients undergoing off-pump surgery showed protection against activation of coagulation and fibrinolysis and against endothelial injury only during the intraoperative period; this was followed by the development of a prothrombotic pattern comparable to that of patients undergoing on-pump surgery lasting at least as late as 30 days after surgery.
本研究调查了体外循环冠状动脉搭桥手术后第一个月内发生的凝血、纤维蛋白溶解和内皮激活情况是否与非体外循环冠状动脉搭桥术后不同。
35例冠状动脉手术候选患者被随机分为接受体外循环(n = 18)或非体外循环(n = 17)冠状动脉搭桥术。在干预前和术后1个月采集血样。
术后凝血酶原片段F1.2、凝血酶 - 抗凝血酶复合物和D - 二聚体增加,在体外循环和非体外循环组中,术后30天这些指标仍持续高于术前值;仅在体外循环结束时(片段F1.2和凝血酶 - 抗凝血酶复合物)或从体外循环结束至术后8天(D - 二聚体),体外循环手术后这些变量的水平相对于非体外循环手术更高。术后纤维蛋白原水平下降,然后两组在术后8天内平行升高。两组术后血管性血友病因子水平均升高,术后30天恢复至基线;从体外循环结束至术后8天,体外循环手术后该指标更高。可溶性血管细胞黏附分子1在术后30天两组均较基线显著升高,两组间无差异。
接受非体外循环手术的患者仅在术中表现出对凝血和纤维蛋白溶解激活以及内皮损伤的保护作用;随后出现与接受体外循环手术患者相当的血栓前状态,至少持续至术后30天。